Arizona State Retirement System Sage Therapeutics, Inc. Transaction History

Arizona State Retirement System

$15.6 Billion
Q3 2024

A detailed history of Arizona State Retirement System transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 12,997 shares of SAGE stock, worth $76,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,997

Previous 12,620 2.99%

Holding current value

$76,552

Previous $137,000 32.12%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.02 - $13.08 $2,646 - $4,931	377 Added 2.99%	12,997 $93,000
Q2 2024 Aug 05, 2024	SELL	$10.58 - $17.9 $23,582 - $39,899	-2,229 Reduced 15.01%	12,620 $137,000
Q1 2024 May 07, 2024	SELL	$18.62 - $26.95 $4,059 - $5,875	-218 Reduced 1.45%	14,849 $278,000
Q4 2023 Jan 24, 2024	SELL	$17.1 - $22.26 $4,223 - $5,498	-247 Reduced 1.61%	15,067 $326,000
Q3 2023 Nov 06, 2023	BUY	$16.75 - $48.98 $3,651 - $10,677	218 Added 1.44%	15,314 $315,000
Q2 2023 Aug 01, 2023	SELL	$40.65 - $59.54 $16,991 - $24,887	-418 Reduced 2.69%	15,096 $709,000
Q1 2023 Apr 27, 2023	BUY	$37.27 - $46.57 $15,802 - $19,745	424 Added 2.81%	15,514 $650,000
Q4 2022 Feb 07, 2023	BUY	$32.2 - $43.61 $20,736 - $28,084	644 Added 4.46%	15,090 $575,000
Q3 2022 Nov 07, 2022	BUY	$32.28 - $43.27 $2,517 - $3,375	78 Added 0.54%	14,446 $566,000
Q2 2022 Jul 28, 2022	BUY	$27.52 - $37.99 $1,018 - $1,405	37 Added 0.26%	14,368 $464,000
Q1 2022 May 04, 2022	BUY	$30.71 - $45.71 $2,610 - $3,885	85 Added 0.6%	14,331 $474,000
Q4 2021 Feb 04, 2022	SELL	$37.06 - $47.11 $3,372 - $4,287	-91 Reduced 0.63%	14,246 $606,000
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $2,174 - $3,097	54 Added 0.38%	14,337 $635,000
Q2 2021 Aug 02, 2021	SELL	$54.88 - $79.29 $47,580 - $68,744	-867 Reduced 5.72%	14,283 $811,000
Q1 2021 May 06, 2021	BUY	$70.65 - $96.76 $5,298 - $7,257	75 Added 0.5%	15,150 $1.13 Million
Q4 2020 Jan 28, 2021	SELL	$58.41 - $89.06 $34,520 - $52,634	-591 Reduced 3.77%	15,075 $1.3 Million
Q3 2020 Nov 05, 2020	BUY	$41.13 - $62.45 $162,422 - $246,615	3,949 Added 33.7%	15,666 $958,000
Q2 2020 Aug 04, 2020	SELL	$25.95 - $43.15 $11,625 - $19,331	-448 Reduced 3.68%	11,717 $487,000
Q1 2020 May 05, 2020	BUY	$26.15 - $77.24 $318,114 - $939,624	12,165 New	12,165 $349,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $350M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Sage Therapeutics, Inc. Transaction History